- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Patterson, B.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Patterson, B.
Intragenic Suppressors of Dictyostelium Myosin G680 Mutants Demarcate Discrete Structural Elements: Implications for Conformational States of the Motor
Bruce Pattersonaa Department of Molecular and Cell Biology, University of Arizona, Tucson, Arizona 85721
Corresponding author: Bruce Patterson, LSS452, Department of Molecular and Cell Biology, University of Arizona, Tucson, AZ 85721., patterso{at}u.arizona.edu (E-mail).
Communicating editor: D. BOTSTEIN
| ABSTRACT |
|---|
We are using intragenic suppression to generate inferences about currently inaccessible conformations of the molecular motor myosin. We identified 19 unique suppressors of Dictyostelium G680A and G680V mutants and find that they are structurally and chemically restricted, suggestive of specific, compensatory mechanisms of action. Suppressors cluster in two adjacent elements of the myosin structure, one of which is dominated by substitutions that increase the volume of hydrophobic residues. The suppressors outline a general model for the mechanism of suppression of the G680A and G680V alterations. Secondary phenotypes conferred by suppressors independent of the G680 changes demonstrate that they will be useful substrates for biochemical and genetic characterization.
AS the tools of molecular biology have grown ever more powerful, questions about how bio-machines such as pumps, switches, and motors perform their jobs have become increasingly interesting and addressable. One technique that has proven powerful in dissecting pathways has yet to be harnessed for the study of mechanics of individual molecular machines: suppressor genetics. We are addressing this deficit by using suppressor genetics to unlock the secrets of the molecular motor myosin. Starting with a conditionally defective allele of myosin of known biochemical defect, we have isolated a family of intragenic suppressors. The locations and properties of these suppressors yield insights into the structural components of the motor and their conformational states during the course of the stroking cycle.
The starting mutations in this study are the G680A and G680V mutations of Dictyostelium myosin II. The G680V allele was isolated as part of a hunt for mutations conferring cold-sensitive myosin phenotypes (![]()
![]()
![]()
S, on the order of 40-fold. We have therefore proposed that this mutation interrupts the motor cycle at a previously uncharacterized point early in actin binding (![]()
To further understand the defects arising from the alteration of this position in the motor and to discover ways in which the motor could change to compensate for the G680A/V defects, we have isolated intragenic suppressors of each allele. Suppressors potentially provide three important types of information about the functioning of the myosin motor: First, their recovery indicates that despite the apparently pleiotropic defects of the position 680 alterations, the critical defect(s) can be reversed or compensated by single alterations. Second, their locations within crystal structures can give us a first clue as to what functionalities of the motor require alteration to restore function to motors bearing position 680 deficiencies. Third, by biochemically characterizing the consequences of these new alterations, we will further illuminate the defects for which they are compensating and gain insight into the mechanism of the compensation.
Our suppressor isolation methodology relies on the phenotypic consequences of myosin deficiency in Dictyostelium. Cells lacking wild-type myosin function can be maintained on surfaces such as petri dishes, but they are deficient in cytokinesis in suspension, generation of cortical tension (![]()
![]()
![]()
![]()
![]()
We combined a PCR-driven marker rescue strategy with in vivo homologous recombination to localize each suppressor mutation to ~400-nt segments of the myosin gene. These regions were sequenced, and the resident suppressor mutation was identified. G680V suppressors have also been expressed in the absence of the position 680 changes, and their consequences were characterized phenotypically.
In our analysis of mutants, we have made several striking findings: (1) the majority of the suppressors reside at positions in the tertiary structure that are distant from residue 680; at most, one of the ~18 suppressors can potentially contact G680V; (2) a significant fraction of the suppressors are deficient for myosin function in the absence of the position 680 change (i.e., the mutations are mutually suppressing); (3) all the mutations affect highly conserved residues; and (4) one "family" of suppressors highlights a central portion of the myosin structure that is suggestive of their mode of action.
| MATERIALS AND METHODS |
|---|
Strains and media:
Initial experiments were performed in HS10, a cell line in which the myosin heavy chain sequence has been deleted completely (![]()
Cell culture conditions were as described by ![]()
![]()
Plasmids and transformation:
All plasmids introduced into Dictyostelium were based on the pLittle or pTIKL chassis. Myosin genes were introduced as BamHI-SacI fragments that included either the wild-type Dictyostelium promoter (![]()
![]()
resistance. After electroporation, 350 µl of cold HL-5 supplemented with heat-killed K. aerogenes was added to the cuvettes. The mixture was then added to chilled six-well petri dishes containing 1.5 ml HL-5. Cultures were incubated at 22° for 24 hr, and G418 was added to bring cultures to 10 µg/ml G418. After an additional 48 hr, the media was replaced with HL-5 containing 8 µg/ml G418. Resulting transformants were combined for all further experiments. All sequencing was performed on pBluescript or pBC plasmids (Stratagene, La Jolla, CA) bearing PCR-derived fragments of the myosin gene cloned using convenient restriction sites.
Mutagenesis and suppressor isolation:
To isolate suppressors, HS10 or SPERA cells transformed with plasmid bearing a mutant myosin were grown to confluency in a six-well plate. Cells were harvested by trituration and spun gently. Cells were then resuspended in 100 µl HL-5. 10-µl aliquots were dripped onto bacterial lawns (usually 8 spots per 100-mm plate or 18 spots per 150-mm plate). After 24 hr, plaques had cleared and the plates were irradiated with UV light at 800 µJ/cm2 in a Stratalinker (Stratagene). Revertant "blisters" were usually visible within 57 days. Revertants were harvested by scraping the leading edge of a plaque with a toothpick and transferring to a six-well plate. DNA was prepared from these cells using a DNA prep kit (Qiagen, Chatsworth, CA).
Polymerase chain reaction:
PCR was performed using Pfu polymerase (Stratagene). The oligos used were as follows: for the 5' segment of the myosin-coding sequence, PIHDRT, 5'-AGCGGATCCAATTCATGATAGAACTTCA-3', and HLN, 5'-GTCTGTCGACGATGAGGATTTTTCAACGTTGA-3', for the internal segment, VLEQQIL, 5'-TGTTCTAGAACAACAAATTCTCCAAGCC-3' and ELDQ, 5'-TCGGGATCCTGTTGTAATGGATCTTTGTTC-3', and for the 3' segment, GLDSQT, 5'-TGGTCTAGATTCACAAGCCACTATC-3' and ARIE, 5'-TTGTTCTCGAGCTTCTTCAATACGAGC-3'. Subcloning was performed into an engineered myosin vector containing one or more of the following engineered or endogenous restriction sites: BspHI at nucleotide 12 (the A in ATG encoding the start methionine being 1), XbaI at 630, SalI at 937, EcoNI at 1164, XhoI at 1231, XbaI at 1521, BglII at 1782, and XhoI at 2270. In all cases, successful introduction of the mutation was recognized by amplifying the mutation on a PCR fragment with an endpoint at one of these restriction sites that encoded a silent nucleotide change (e.g., changing the BglII site at 1782 to a BamHI site such that a hybrid site was created upon insertion into the wild-type sequence). Sequencing subclones for unmapped G680V suppressors were generated by preparing two PCR products, using oligos PIK 5'-GACTGGTACCAATCAAATTCGATGGTGTC-3' and GAS 5'-pGAAGCACCACTAATGAAACCA-3' as one pair and QERK 5'-TGACGAGCTCTGTCAAGAGAGAAAAGCT-3' and QA-TID 5'-pAAATCGATAGTGGCTTGTGAA-3' as the second. The first product was cut with KpnI, the second with SacI, and the two pieces were cloned end to end into pBluescript (Stratagene) cut with KpnI and SacI and sequenced.
Suppressor mapping:
Plasmids recovered from revertant cells were initially purified and reintroduced into Dictyostelium to check whether or not the suppressor was plasmid linked. Because 100% of recovered plasmids passed this test, however, it was eventually dropped. Suppressors were localized by preparing three PCR fragments using the DNA recovered from each revertant. The three fragments were generated using oligos PIHDRT-HLN, VLEQQIL-ELDQ, and GLDSQT-ARIE. Each fragment was then cotransformed with either plasmid bearing either the G680A or G680V myosin, as appropriate. Fragments were cut with EcoNI (for the PIHDRT-HLN fragment), BstXI (for the VLEQQIL-ELDQ fragment), or BstXI and BglII (for the GLDSQT-ARIE fragment). Transformants were assayed for plaque expansion rate, and those showing 150% or greater rates of expansion compared to the parent plasmid were judged to result from introduction of the suppressor. The location of the suppressor was deduced from examining which PCR fragments conferred suppressor activity. The appropriate region of DNA was then recovered by PCR and sequenced. Once we had established that the majority of G680V suppressors could be found among amino acids 90250 or 400500, we designed a sequencing strategy to recover these regions. We then sequenced them without engaging in mapping, and we mapped only those suppressors that were not identified by sequencing this region.
Growth rate measurements:
Plaque expansion rates were measured on lawns of K. aerogenes that were prepared as described above. Each Dictyostelium strain to be measured was grown to confluence in a six-well petri dish. Cells were harvested by trituration and concentrated by low-speed centrifugation followed by resuspension in 10 µl HL-5. Eight microliters of the suspension was dripped onto a bacterial lawn. Plaque size measurements were made on successive days by comparing the plaque to a set of standard circles. Measurements were continued as long as most plaques demonstrated roughly linear growth rates. Final growth rates were calculated by figuring the total growth over the linear phase divided by the number of days grown. All rates were compared to those of wild type spotted on the same plate to control for variability in plates, lawns, and other environmental variables. The rate compared to that of wild type was generally observed to be reproducible ±10 percentage points.
| RESULTS |
|---|
Isolation of suppressors:
The primary methodology we used in suppressor isolation took advantage of one of the striking phenotypes of myosin deficiency in Dictyostelium: poor colony expansion rates on bacterial lawns. We had previously demonstrated that this phenotype was sufficiently powerful for marker rescue experiments (![]()
Suppressors of G680V were difficult to acquire by the method described above; indeed, only two suppressor events were identified through several rounds of screening dozens of mutagenized plaques. To increase our sensitivity of detection, we took advantage of our ob servation that myosin-null cell lines occasionally give rise to faster-expanding plaques after mutagenesis (B. PATTERSON, unpublished data). Reasoning that these changes might confer still more rapid expansion in the presence of functional myosin, we performed two rounds of selection for more rapidly expanding myosin-null cell lines. The resulting cell line was designated the SPERA line. While SPERA cells were only mildly enhanced in plaque expansion compared to their predecessors (11.2 vs. 0.60.8 mm/day), addition of the wild-type myosin gene resulted in marked improvement in plaque expansion rates over parental cells transformed with wild-type myosin genes (67 vs. 2.53.5 mm/day). One important side effect of the mutation(s) resulting in rapid plaque expansion is that cells no longer aggregate or form fruiting bodies. We have not determined whether blocking aggregation is sufficient to convert wild-type Dictyostelium cells to a rapid aggregation phenotype, although preventing aggregation using 2 mM caffeine does not enhance the plaque expansion rate (B. PATTERSON, unpublished data).
When the G680V myosin gene was introduced into the SPERA cell line, plaque expansion rates were comparable to cells lacking myosin. After UV mutagenesis, however, we were able to recover rapid plaque expansion mutants. While only ~10% of these proved to express the G418 resistance anticipated for cells containing the G680V-expressing plasmid, all of these contained myosins bearing intragenic suppressors to the G680V mutation.
Localization and sequencing of suppressors:
To map the suppressing mutations, we developed a strategy related to gap repair used in Saccharomyces cerevisiae gene studies. We induced homologous recombination between PCR fragments derived from the suppressor plasmids and from plasmids containing only the G680A or G680V mutations by using restriction enzymes to introduce "gaps" in the target plasmids. A series of PCR fragments were generated such that in sum, they overlapped to include DNA encoding the entire myosin head domain (2500 nt) but were individually 8001000 nt in length. Plasmids bearing the starting mutation, but not the suppressor, were cut at sites spanned by the PCR fragment being tested (in imitation of procedures used to enhance homologous recombination in Saccharomyces). Cut plasmid and PCR fragment were coelectroporated into the SPERA cell line, and transformants were selected for G418 resistance arising from a marker borne on the target plasmid. Populations of transformants arising from a single transformation were mixed and tested for plaque expansion rate; those exhibiting rates indicative of suppression of the mutation were concluded to have arisen from PCR fragments bearing the suppressor.
Once the region bearing the intragenic suppressor mutation had been narrowed down to ~500 nt or less, a fragment spanning the region was cloned into a vector for sequencing. The nucleotide sequence was then determined, and in virtually all cases, it contained a suppressor mutation. In those cases where no suppressor was detected, the adjacent region was mapped, and in all cases, a suppressor was found; we conclude that this inaccuracy in the mapping arises from "run-on" PCR products that we failed to destroy in the nuclease step (see MATERIALS AND METHODS). The DNA sequence changes and predicted amino acid alterations are shown in Table 1.
|
Expression of suppressors:
For a suppressor to be fully useful, it must have altered properties beyond merely countering the defect caused by the original mutation. For this reason, we separated several of the suppressors from the generative position 680 mutation and tested their properties in vivo. Mutants were separated by using PCR of a region containing only the suppressor followed by replacement of a fragment from an otherwise wild-type myosin gene using convenient restriction sites. Mutants generated in this manner were then tested for myosin function using the plaque expansion rate assay described above. While many of the suppressors of the G680V mutation behaved essentially as nulls in the plaque expansion assay (Table 2), those that suppressed only G680A were indistinguishable from wild type (B. PATTERSON, unpublished data). However, several G680A suppressors were also capable of suppressing G680V and conferring growth defects in isolation of G680 changes; conversely, several G680V suppressors (such as G182C and E476Q) confer little, if any, plaque expansion rate phenotype on their own.
|
| DISCUSSION |
|---|
We have pioneered a suppressor-driven approach to myosin structure/function. By isolating intragenic revertants of G680V, a Dictyostelium myosin II cold-sensitive mutant, we have (1) demonstrated that the initial G680V defect can be repaired (at the level of biological phenotype) by single amino acid alterations, (2) demonstrated a compensatory relationship between changes in amino acid volume at (at least) two noncontiguous positions in the myosin structure, (3) generated tools for further understanding both the initial defect and its remediation, and (4) heightened our focus on the enigmatic 466496
-helix.
Position 680 mutations can be suppressed by altering highly conserved residues within myosin:
The first question of this approach was whether the G680A and G680V mutations could be suppressed at all. These mutations change an absolutely conserved glycine residue and give rise to mutants with a variety of apparent defects, including altered nucleotide affinity and extended actin-binding times. While the fact that the mutants are only cold sensitive rather than completely inactive suggested that they were not irreparably altered "monsters," the search for compensatory changes within myosin was unprecedented.
The isolation of 19 different intragenic suppressors clearly demonstrates that the mutations at position 680 can be compensated by several alterations elsewhere in the motor domain. Indeed, by visual inspection of the three-dimensional locations of the suppressors, it is difficult to neatly assign all the suppressors to a single functional element of the motor, such as Pi release. This suggests the possibility that there may be a variety of ways to "tweak" the motor back to function. Preliminary biochemical analysis of the suppressors suggests that this is indeed the case (Y. WU and B. PATTERSON, unpublished results).
Even in the absence of biochemical characterization, the locations of the mutations indicate that they are altering critical residues. All of the suppressors affect highly conserved residues, some absolutely so (see Table 1). For example, P128Q, G182C, N235D, L453F/Y, G240N, and E476Q all change residues absolutely conserved among all myosins, while M91I, N483S, and L676F change residues absolutely conserved in myosin II.
Besides changing only conserved residues, suppressors show striking clustering in the primary structure. By displaying the positions of unique changes (changes at the same position were only counted once unless the changes produced different amino acids), we detect distinct groupings (see Figure 1). Four-fifths of the mutants affect residues between positions 100 and 200 or 450 and 500. This interval comprises approximately one-fifth of the motor domain-encoding sequences. Viewing the tertiary structure (Figure 2A), we detect no changes at either end of the molecule, and there was a clustering of alterations in a belt or disk centered around the ATP-binding site. This localization clearly excludes all the actin-binding sites as well as the light chain-binding domain.
|
|
Analysis of G680A and G680V suppressors:
The chemical changes represented in the collection are extremely nonrandom. While at the DNA level we detect all six distinguishable transitions and transversions, the predicted amino acid changes are dramatically skewed: more than one-third of the changes are L
F alterations (counting each change at a given position once regardless of duplication), whereas of the remaining changes, only two (G
C and I
M) are represented twice, and the rest are represented once. While it is difficult to calculate the effect of UV light mutagenesis on different codons (e.g., there are 6 leucine codons, and we have only recovered those of the form TTPurine changed to phenylalanine), it would nonetheless appear that alteration of leucine to phenylalanine is overrepresented in the collection. These changes are distributed evenly in the primary structure, with one in each of the intervals shown in Figure 1, except for only the 50100 interval.
Even more striking is the fact that of the 19 amino acid changes observed, only one, N483S, substitutes a markedly smaller amino acid for a larger one (Table 1). This position is also distinctive in that it is the only one which could directly interact with position G680. This alteration is thus the only possible instance of a "lock and key" type of suppression in which an alteration in a directly interacting amino acid compensates for the primary lesion by restoring the wild-type structure. It should also be noted that this residue, along with E476, is on the opposite side of the 466496
-helix that we believe to be a primary focus of G680V suppressors (see below).
The fact that the G680V mutation, itself a substitution of a large hydrophobic residue for a smaller one, is suppressed by increasing the size of other, primarily hydrophobic residues illuminates the mechanism of suppression. It is highly unlikely that these changes reverse or directly compensate the defect introduced by the G680V alteration [presumably derived from increased volume of the side chain; the G680A change is biologically and biochemically milder (![]()
It is notable that several of the suppressors alter residues in regions of assigned function or that have been biochemically characterized in other studies. Perhaps the most notable of these is the G182C change that alters an absolutely conserved residue in the "P loop" (![]()
-phosphates of ATP. In F1-ATPase, the residue corresponding to G182 is also a glycine, and its alteration to cysteine has been genetically characterized and found to give rise to cold sensitivity (![]()
Several of the mutations alter residues that are close to highly conserved elements of P-loop proteins or that feature prominently in models of myosin function. L453 is adjacent to residues 455 and 457, about which critical rotations and angle changes take place in the conformational alterations that have been seen in myosin to date (![]()
![]()
![]()
![]()
![]()
The tightest clustering observed among the suppressors is the group L175F, L176F, I177M, T189I, I193M, and L453F. This group defines a discrete cluster of residues in the myosin structure (Figure 2B and Figure C). Visual inspection of this region of myosin suggested that changes at residue V192 might have similar effects on the structure. Because we had recovered V192F in our original screen for cold-sensitive mutants (in strains HS94 and HS109; ![]()
![]()
![]()
![]()
Three observations lead us to consider the possibility that the Cluster suppressors (L175F, L176F, I177M, T189I, V192F, I193M, and L453F) were acting via steric constraint of helix 466496: (1) the close apposition of the "Cluster" mutants, particularly residues L453 and L176, to the 466496 helix, (2) our previous observation of the conspicuousness of the 466496 helix as a target for cold-sensitive mutants [residues 467 and 494 are helix elements that can mutate to cold sensitivity, as can nearby residues 501, 680, and 691 (![]()
The E476Q and N483S mutations reside in the highly conserved
-helix (residues 466496 in Dictyostelium myosin) mentioned above. It is interesting to note that these residues, separated by two turns of the helix, both face the outside of the molecule away from the 175, 176, 177, 189, 192, 193, 453 Cluster discussed above. The E476Q alteration is identical to one introduced and characterized by ![]()
A final critical point is that the majority of the G680V suppressors confer significant biological defects when isolated from the generative mutation. As with intergenic suppression (![]()
![]()
![]()
Cold-sensitive myosin mutations suppress one another:
One unanticipated result of this work was the finding that three of our original cold-sensitive mutants could suppress the cold-sensitive G680V mutation. These were V192F, G240C, and G240V. The suppressor screen identified changes at position T189 and I193, prompting us to test the V192F alteration, while recovery of G240N prompted us to test the G240C and G240V mutants. In all cases, we observed suppression of the G680V mutation. The discovery that 3 of our original ~20 cold-sensitive mutants can suppress a fourth suggests the possibility that there are only a small number of ways in which cold-sensitive myosin function can be induced, and that the states or changes induced are in some way complementary. We have also observed this phenomenon in our characterization of actin-binding site, cold-sensitive mutants, where at least two more of the original cold-sensitive mutants have been found in suppressor screens (E. MISNER and B. PATTERSON, unpublished results; ![]()
A mechanical model for G680V and its suppressors:
The striking feature of the locations of the suppressors vis-à-vis the G680V mutation is their relationship to the 466496 helix. The addition of a valine side chain at position 680 would impinge upon this helix and constrain potential movements of the helix. It is therefore noteworthy that the Cluster group of suppressors (positions 175177, 189, 192, and 453) increase the volume of residues on another face of the helix. Yet another suppressor, L638F, increases the volume of another side chain that is oriented toward the helix, opposite position G680. Finally, the change at position N483, on the opposite face of the helix from the Cluster, suppresses when changed to a smaller residue (the E476Q change is difficult to interpret in this light). These observations suggest that the effect of the suppressor changes is to "rebalance" constraints on the movement or positioning of the helix induced by the G680V change. One prediction of this model is that the defects introduced by the Cluster suppressors in the absence of the G680V change arise by "unbalanced" shifting of the helix opposite that induced by G680V. In this regard, it is interesting to note that helix 466496 undergoes significant rotation and bending between the Dictyostelium myosin vanadate or AlF structures (![]()
![]()
![]()
![]()
![]()
Future directions:
The mutants already in hand demonstrate the feasibility of our approach and offer several hints as to pathways of communication and conformational change operating within the myosin motor. We are currently engaging in biochemical characterization of these new mutants, primarily in the absence of the G680V mutation, to more precisely define the perturbations they introduce. Preliminary data indicate that the Cluster mutants share common biochemical defects consistent with compensation of the G680V-induced perturbations (Y. WU, M. NEJAD and B. PATTERSON, unpublished results). By comparing these changes to each other and to those we have characterized for G680V, we intend to map out a more complete picture of the mechanics of the myosin motor. We are also investigating the possibility that the 466496 helix represents a key effector of myosin conformations because a large number of cold-sensitive mutants and suppressors (including G680V, the Cluster, E476Q, N483S, and L638F) lie in and around it. Details of ongoing work can be found at http://research.biology.arizona.edu/myosin/.
| ACKNOWLEDGMENTS |
|---|
We gratefully acknowledge TARO UYEDA and ROY PARKER for enlightening discussions, MIKE NEJAD and the LMSE DNA sequencing service at the University of Arizona for expert technical assistance, and THERENCE DECORSE and MEGHAN KREEGER for media creation. This work was supported by National Institutes of Health grant GM55977. Figures were generated using SPDBviewer and POV-Ray software.
Manuscript received February 23, 1998; Accepted for publication May 18, 1998.
| LITERATURE CITED |
|---|
ADAMS, A. E. M. and D. BOTSTEIN, 1989 Dominant suppressors of yeast actin mutations that are reciprocally suppressed. Genetics 121:675-683
CHOTHIA, C., 1975 Structural invariants in protein folding. Nature 254:304-308[Medline].
DE LOZANNE, A. and J. A. SPUDICH, 1987 Disruption of the Dictyostelium myosin heavy chain gene by homologous recombination. Science 236:1086-1091
EGELHOFF, T. T., D. J. MANSTEIN, and J. A. SPUDICH, 1990 Complementation of myosin null mutants in Dictyostelium discoideum by direct functional selection. Dev. Biol. 137:359-367[Medline].
FISHER, A. J., C. A. SMITH, J. B. THODEN, R. SMITH, and K. SUTOH et al., 1995 X-ray structures of the myosin motor domain of Dictyostelium discoideum complexed with MgADP · BeFx and MgADP · AlF4. Biochemistry 34:8960-8972[Medline].
JARVIK, J. and D. BOTSTEIN, 1975 Conditional-lethal mutations that suppress genetic defects in morphogenesis by altering structural proteins. Proc. Natl. Acad. Sci. USA 72:2738-2742
KNECHT, D. A. and W. F. LOOMIS, 1987 Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum.. Science 236:1081-1086
KNECHT, D. A. and W. F. LOOMIS, 1988 Developmental consequences of the lack of myosin heavy chain in Dictyostelium discoideum.. Dev. Biol. 128:178-184[Medline].
PASTERNAK, C., P. F. FLICKER, S. RAVID, and J. A. SPUDICH, 1989 Intermolecular versus intramolecular interactions of Dictyostelium myosin: possible regulation by heavy chain phosphorylation. J. Cell Biol. 109:203-210
PATTERSON, B. and J. A. SPUDICH, 1995 A novel positive selection for identifying coldsensitive myosin II mutants in Dictyostelium.. Genetics 140:505-515[Abstract].
PATTERSON, B. and J. A. SPUDICH, 1996 Cold-sensitive mutations of Dictyostelium myosin heavy chain highlight functional domains of the myosin motor. Genetics 143:801-810[Abstract].
PATTERSON, B., K. M. RUPPEL, Y. WU, and J. A. SPUDICH, 1997 Cold-sensitive mutants G680V and G691C of Dictyostelium myosin II confer dramatically different biochemical defects. J. Biol. Chem. 272:27612-27617
RAYMENT, I., W. RYPNIEWSKI, K. SCHMIDT-BASE, R. SMITH, and D. TOMCHICK et al., 1993 The three-dimensional structure of a molecular motor, myosin subfragment-1. Science 261:50-58
RUPPEL, K. M. and J. A. SPUDICH, 1996 Structure-function studies of the myosin motor domain: importance of the 50-kDa cleft. Mol. Biol. Cell 7:1123-1136[Abstract].
RUPPEL, K. M., T. Q. P. UYEDA, and J. A. SPUDICH, 1994 Role of highly conserved lysine 130 of myosin motor domain. J. Biol. Chem. 269:18773-18780
SELLERS, J. R. and H. V. GOODSON, 1995 Motor proteins 2: myosin. Protein Profile 2:1323-1423[Medline].
SHEN, H., B.-Y. YAO, and D. M. MUELLER, 1994 Primary structural constraints of P-loop of mitochondrial F1-ATPase from yeast. J. Biol. Chem. 269:9424-9428
SHIMADA, T., N. SASAKI, R. OHKURA, and K. SUTOH, 1997 Alanine scanning mutagenesis of the Switch I region in the ATPase site of Dictyostelium discoideum Myosin II. Biochemistry 36:14037-14043[Medline].
SHORTLE, D. and B. LIN, 1985 Genetic analysis of staphylococcal nuclease: identification of three intragenic "global" suppressors of nuclease-minus mutations. Genetics 110:539-555, pp
SMITH, C. A. and I. RAYMENT, 1996a Active site comparisons highlight structural similarities between myosin and other P-loop proteins. Biophys. J. 70:1590-1602
SMITH, C. A. and I. RAYMENT, 1996b X-ray structure of the magnesium(II) · ADP · vanadate complex of the Dictyostelium discoideum myosin motor domain to 1.9Å resolution. Biochemistry 35:5404-5417[Medline].
SUSSMAN, M., 1987 Cultivation and synchronous morphogenesis of Dictyostelium under controlled experimental conditions, pp. 929 in Dictyostelium discoideum: Molecular Approaches to Cell Biology, edited by J. A. SPUDICH. Academic Press, Orlando.
YOUNT, R. G., D. LAWSON, and I. RAYMENT, 1995 Is myosin a "back door" enzyme? Biophys. J. 68:44s-49s.
This article has been cited by other articles:
![]() |
J. D. Lawson, E. Pate, I. Rayment, and R. G. Yount Molecular Dynamics Analysis of Structural Factors Influencing Back Door Pi Release in Myosin Biophys. J., June 1, 2004; 86(6): 3794 - 3803. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, T. Q. P. Uyeda, Y. Suzuki, K. Sutoh, and K. Yamamoto Requirement of Domain-Domain Interaction for Conformational Change and Functional ATP Hydrolysis in Myosin J. Biol. Chem., August 15, 2003; 278(33): 31049 - 31057. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, M. Nejad, and B. Patterson Dictyostelium Myosin II G680V Suppressors Exhibit Overlapping Spectra of Biochemical Phenotypes Including Facilitated Phosphate Release Genetics, September 1, 1999; 153(1): 107 - 116. [Abstract] [Full Text] |
||||
- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Patterson, B.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Patterson, B.



